Application of 1, 2, 6-tri-O-galloyl-beta-D-glucopyranose to preparation of anti-coronavirus drugs
The application is a divisional application with an application number of 202011453321.9 and an application date of December 11, 2020, and the divisional application is named as Application of gallicacid and derivatives and structural analogues thereof to preparation of anti-coronavirus drugs. The invention belongs to the technical field of biological drugs, and particularly relates to an application of 1, 2, 6-tri-O-galloyl-beta-D-glucopyranose to preparation of anti-coronavirus drugs. Researches show that the 1, 2, 6-tri-O-galloyl-beta-D-glucopyranose has an obvious antiviral effect on various coronaviruses, including 2019 novel coronaviruses (2019-nCoV or SARS-CoV-2), MERS-CoV (Middle East Respiratory Syndrome CoV) and the like. Moreover, the 1, 2, 6-tri-O-galloyl-beta-D-glucopyranoseis natural in source, widely exists in various plants, is widely applied to the fields of foods, biology and medicines, and is very safe, so that the 1, 2, 6-tri-O-galloyl-beta-D-glucopyranose has very good application value in the aspect of preparing and developing antiviral drugs for coronaviruses..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Europäisches Patentamt - (2021) vom: 16. März Zur Gesamtaufnahme - year:2021 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
FU JUN [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-03-16, Last update posted on www.tib.eu: 2022-04-11, Last updated: 2023-02-09 |
---|
Patentnummer: |
CN112494504 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA011484659 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA011484659 | ||
003 | DE-627 | ||
005 | 20230504130012.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210601s2021 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA011484659 | ||
035 | |a (EPA)CN112494504 | ||
035 | |a (EPA)72386666 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a FU JUN |e verfasserin |4 aut | |
245 | 1 | 0 | |a Application of 1, 2, 6-tri-O-galloyl-beta-D-glucopyranose to preparation of anti-coronavirus drugs |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2021-03-16, Last update posted on www.tib.eu: 2022-04-11, Last updated: 2023-02-09 | ||
520 | |a The application is a divisional application with an application number of 202011453321.9 and an application date of December 11, 2020, and the divisional application is named as Application of gallicacid and derivatives and structural analogues thereof to preparation of anti-coronavirus drugs. The invention belongs to the technical field of biological drugs, and particularly relates to an application of 1, 2, 6-tri-O-galloyl-beta-D-glucopyranose to preparation of anti-coronavirus drugs. Researches show that the 1, 2, 6-tri-O-galloyl-beta-D-glucopyranose has an obvious antiviral effect on various coronaviruses, including 2019 novel coronaviruses (2019-nCoV or SARS-CoV-2), MERS-CoV (Middle East Respiratory Syndrome CoV) and the like. Moreover, the 1, 2, 6-tri-O-galloyl-beta-D-glucopyranoseis natural in source, widely exists in various plants, is widely applied to the fields of foods, biology and medicines, and is very safe, so that the 1, 2, 6-tri-O-galloyl-beta-D-glucopyranose has very good application value in the aspect of preparing and developing antiviral drugs for coronaviruses. | ||
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 16. März |
773 | 1 | 8 | |g year:2021 |g day:16 |g month:03 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/72386666/publication/CN112494504A1?q=CN112494504 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2021 |b 16 |c 03 |
951 | |a AR | ||
952 | |j 2021 |b 16 |c 03 |